These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 25253819)

  • 1. Detection of fetal structural anomalies in a basic first-trimester screening program for aneuploidy.
    Bromley B; Shipp TD; Lyons J; Navathe RS; Groszmann Y; Benacerraf BR
    J Ultrasound Med; 2014 Oct; 33(10):1737-45. PubMed ID: 25253819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the importance of second-trimester "soft markers" for trisomy 21 after an 11- to 14-week aneuploidy screening scan?
    Bromley B; Shipp TD; Lyons J; Groszmann Y; Navathe RS; Benacerraf BR
    J Ultrasound Med; 2014 Oct; 33(10):1747-52. PubMed ID: 25253820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
    Tang HR; Zhang Y; Ru T; Li J; Yang L; Xu Y; Duan HL; Wang Y; Wang Y; Hu YL; Zhang Y; Zheng MM
    Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):94-99. PubMed ID: 32146737
    [No Abstract]   [Full Text] [Related]  

  • 4. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan.
    Becker R; Wegner RD
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):613-8. PubMed ID: 16570262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse pregnancy outcome in fetuses with early increased nuchal translucency: prospective cohort study.
    Bet BB; Lugthart MA; Linskens IH; van Maarle MC; van Leeuwen E; Pajkrt E
    Ultrasound Obstet Gynecol; 2024 Aug; 64(2):164-172. PubMed ID: 38411313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
    Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
    Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound detection of fetal anomalies in conjunction with first-trimester nuchal translucency screening: a feasibility study.
    McAuliffe FM; Fong KW; Toi A; Chitayat D; Keating S; Johnson JA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1260-5. PubMed ID: 16157148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crown-Rump Length Discordance, Increased Nuchal Translucency, and Detection of Fetal Structural Anomalies in Twin Pregnancies in the First Trimester: 5 Years of Experience in a Tertiary Hospital in China.
    Li X; Xuan Y; Wang J; Wang L; Papageorghiou AT; Wu Q
    J Ultrasound Med; 2022 Apr; 41(4):971-982. PubMed ID: 34289155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First trimester ultrasonography in screening and detection of fetal anomalies.
    Sonek J
    Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):45-61. PubMed ID: 17304542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic value of a detailed first trimester anomaly scan in fetuses with increased nuchal translucency thickness.
    Tekesin I
    J Perinat Med; 2019 Feb; 47(2):241-246. PubMed ID: 30218607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is nuchal translucency a useful aneuploidy marker in fetuses with crown-rump length of 28-44 mm?
    Grande M; Solernou R; Ferrer L; Borobio V; Jimenez JM; Bennasar M; Soler A; Borrell A
    Ultrasound Obstet Gynecol; 2014 May; 43(5):520-4. PubMed ID: 24006271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for structural fetal anomalies during the nuchal translucency ultrasound examination.
    Weiner Z; Goldstein I; Bombard A; Applewhite L; Itzkovits-Eldor J
    Am J Obstet Gynecol; 2007 Aug; 197(2):181.e1-5. PubMed ID: 17689643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era.
    Kenkhuis MJA; Bakker M; Bardi F; Fontanella F; Bakker MK; Fleurke-Rozema JH; Bilardo CM
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):463-469. PubMed ID: 28397377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The added value of detailed early anomaly scan in fetuses with increased nuchal translucency.
    Zalel Y; Zemet R; Kivilevitch Z
    Prenat Diagn; 2017 Mar; 37(3):235-243. PubMed ID: 28010037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.
    Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y
    Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing visualization of the intracranial translucency during first-trimester screening for aneuploidy.
    Beamon CJ; Stuebe AM; Wolfe HM
    Am J Perinatol; 2012 Aug; 29(7):503-8. PubMed ID: 22495902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of first-trimester sonography in the diagnosis of aneuploidy and structural fetal anomalies.
    Abu-Rustum RS; Daou L; Abu-Rustum SE
    J Ultrasound Med; 2010 Oct; 29(10):1445-52. PubMed ID: 20876898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal brain anomalies detection during the first trimester: expanding the scope of antenatal sonography.
    Katorza E; Gat I; Duvdevani N; Meller N; Pardo N; Barzilay E; Achiron R
    J Matern Fetal Neonatal Med; 2018 Feb; 31(4):506-512. PubMed ID: 28282781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ultrasound screening and diagnosis of fetal structural abnormalities between 11-14 gestational weeks].
    Markov D; Chernev T; Dimitrova V; Mazneĭkova V; Leroy Y; Jacquemyn Y; Ramaekers P; Van Bulck B; Loquet P
    Akush Ginekol (Sofiia); 2004; 43(3):3-10. PubMed ID: 15341249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal anatomy scan with integrated nuchal translucency and combination of PAPP-A and fβhCG for prediction of aneuploidy.
    Kornanova E; Dugatova M; Vaclavova Z; Borovsky M
    Bratisl Lek Listy; 2022; 123(4):299-303. PubMed ID: 35294217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.